title: Clinical approval: Trials of an anticancer jab.
authors.forename: Julie
authors.initials: J
authors.lastname: Clayton
mesh_terms: D000293:Adolescent; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D005260:Female; D005500:Follow-Up Studies; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D038622:Internationality; D008297:Male; D027383:Papillomaviridae / Q000145:classification / Q000276:immunology* / Q000472:pathogenicity; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology*; D014611:Vaccination / Q000706:statistics & numerical data
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18